StonvexLoading…
StonvexStonvexStonvexCore line items from GATX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.74B | $1.59B | $1.41B | $1.27B |
Operating Income | $279.10M | $261.40M | $245.50M | $177.10M |
Net Income | $333.30M | $284.20M | $259.20M | $155.90M |
EPS (Diluted) | $9.12 | $7.78 | $7.12 | $4.35 |
Total Assets | $18.00B | $12.30B | $11.33B | $10.07B |
Total Liabilities | $14.36B | $9.86B | $9.05B | $8.04B |
Cash & Equivalents | $743.00M | $401.60M | $450.70M | $303.70M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-1.14B | $-722.30M |
Shares Outstanding | 35.40M | 35.58M | 35.46M | 35.27M |